LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article: Quantitative analysis of human hairs and nails.

    Bali, Varun / Khajuria, Yugal / Maniyar, Vidit / Rai, Pradeep K / Kumar, Upendra / Ghany, Charles / Gondal, M A / Singh, Vivek K

    Biophysical reviews

    2023  Volume 15, Issue 3, Page(s) 401–417

    Abstract: Hair and nails are human biomarkers capable of providing a continuous assessment of the concentrations of elements inside the human body to indicate the nutritional status, metabolic changes, and the pathogenesis of various human diseases. Laser-induced ... ...

    Abstract Hair and nails are human biomarkers capable of providing a continuous assessment of the concentrations of elements inside the human body to indicate the nutritional status, metabolic changes, and the pathogenesis of various human diseases. Laser-induced breakdown spectroscopy (LIBS) and X-ray fluorescence (XRF) spectrometry are robust and multi-element analytical techniques able to analyze biological samples of various kinds for disease diagnosis. The primary objective of this review article is to focus on the major developments and advances in LIBS and XRF for the elemental analysis of hair and nails over the last 10-year period. The developments in the qualitative and quantitative analyses of human hair and nail samples are discussed in detail, with special emphasis on the key aspects of elemental imaging and distribution of essential and non-essential elements within the hair and nail tissue samples. Microchemical imaging applications by LIBS and XRF (including micro-XRF and scanning electron microscopy, SEM) are also presented for healthy as well as diseased tissue hair and nail samples in the context of disease diagnosis. In addition, main challenges, prospects, and complementarities of LIBS and XRF toward analyzing human hair and nails for disease diagnosis are also thoroughly discussed here.
    Language English
    Publishing date 2023-06-20
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 2486483-3
    ISSN 1867-2469 ; 1867-2450
    ISSN (online) 1867-2469
    ISSN 1867-2450
    DOI 10.1007/s12551-023-01069-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: When You "Can't See" a Case of Relapsing Polychondritis.

    Contreras, David / Dhillon, Navpreet / Sharma, Rupam / Bali, Varun / Katayon, Sabetian / Quynh, Bao / Heidari, Arash

    Journal of investigative medicine high impact case reports

    2021  Volume 9, Page(s) 23247096211052175

    Abstract: Relapsing polychondritis (RP) is a rare and, if not treated, potentially lethal autoimmune disorder. Involvement of central nervous system (CNS) in RP is rare and, when present, makes it extremely difficult to diagnose. In this report, we present a case ... ...

    Abstract Relapsing polychondritis (RP) is a rare and, if not treated, potentially lethal autoimmune disorder. Involvement of central nervous system (CNS) in RP is rare and, when present, makes it extremely difficult to diagnose. In this report, we present a case of a 22-year-old Hispanic woman who presented with sudden onset of headache and blurred vision. Magnetic resonance imaging (MRI) of her brain and orbit showed leptomeningeal enhancements in addition to asymmetrical thickening and enhancement of globes. Her lumbar puncture was consistent with aseptic meningitis picture, and she was placed on empirical treatment for presumptive CNS tuberculosis. Her vision deteriorated, and she was diagnosed with RP with CNS and ocular involvement and placed on high-dose steroids with dramatic rapid response. She has been on immunosuppressive treatment, including Sulfasalazine and Methotrexate, since then and her disease has been under control with decreased need for ophthalmic steroid drops. There have been only 19 previous cases found in literature reporting an association of RP with CNS involvement.
    MeSH term(s) Adult ; Brain/diagnostic imaging ; Female ; Humans ; Immunosuppressive Agents ; Magnetic Resonance Imaging ; Meningitis, Aseptic ; Polychondritis, Relapsing/diagnosis ; Polychondritis, Relapsing/drug therapy ; Young Adult
    Chemical Substances Immunosuppressive Agents
    Language English
    Publishing date 2021-10-18
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 2710326-2
    ISSN 2324-7096 ; 2324-7096
    ISSN (online) 2324-7096
    ISSN 2324-7096
    DOI 10.1177/23247096211052175
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: A Case of S-Variant Hepatitis B Virus: An Immune System Escape Artist.

    Shah, Amar S / Civelli, Valerie F / Bali, Varun / Johnson, Royce H / Heidari, Arash

    Journal of investigative medicine high impact case reports

    2021  Volume 9, Page(s) 23247096211045450

    Abstract: Genomic variants of the hepatitis B virus (HBV) preS/S protein are well-known to occur. Typically, immunity is gained through recovered HBV infection or by immunization. Very rarely, there are certain mutations that may enable HBV escape from the immune ... ...

    Abstract Genomic variants of the hepatitis B virus (HBV) preS/S protein are well-known to occur. Typically, immunity is gained through recovered HBV infection or by immunization. Very rarely, there are certain mutations that may enable HBV escape from the immune detection. PreS/S mutants may present with unpredictable pathobiologic, clinical, and transmittable implications. Standard laboratory testing for genomic HBV variants is not routinely performed by reference guidelines. s-variant HBV management remains challenging. Herein is a case of s-variant chronic HBV infection in a 55-year-old man. Diagnosis and treatment are described.
    MeSH term(s) Genetic Variation ; Hepatitis B/diagnosis ; Hepatitis B Surface Antigens ; Hepatitis B virus/genetics ; Humans ; Immune System ; Male ; Middle Aged
    Chemical Substances Hepatitis B Surface Antigens
    Language English
    Publishing date 2021-09-14
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 2710326-2
    ISSN 2324-7096 ; 2324-7096
    ISSN (online) 2324-7096
    ISSN 2324-7096
    DOI 10.1177/23247096211045450
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Outcomes After Acute Symptomatic Seizures in Children Admitted to a Neonatal Neurocritical Care Service.

    Glass, Hannah C / Numis, Adam L / Gano, Dawn / Bali, Varun / Rogers, Elizabeth E

    Pediatric neurology

    2018  Volume 84, Page(s) 39–45

    Abstract: Background: Neonatal seizures due to acute brain injury are associated with high rates of death, disability, and epilepsy. Our objective was to examine incidence of and risk factors for epilepsy among survivors of acute symptomatic neonatal seizures who ...

    Abstract Background: Neonatal seizures due to acute brain injury are associated with high rates of death, disability, and epilepsy. Our objective was to examine incidence of and risk factors for epilepsy among survivors of acute symptomatic neonatal seizures who were cared for by a neonatal neurocritical care service.
    Methods: Neonates with acute symptomatic seizures who were admitted to UCSF Benioff Children's Hospital Neuro-Intensive Care Nursery from July 2008 to June 2014 were considered for inclusion.
    Results: A total of 144 children with acute symptomatic seizures met study criteria and 37 (26%) died before age one. Eighty-seven children (85% of eligible survivors) were followed up to one year or longer. Epilepsy was diagnosed in eight children at median age 4.9 (interquartile range 1.7, 6.1) years. The cumulative incidence risk of epilepsy at one year was 2% (95% confidence interval 0.6% to 9%) and at five years was 7% (95% confidence interval 3% to 20%). Cerebral palsy was diagnosed in 21%. Bayley-III cognitive subscale less than 85 was present in 13%. Children with epilepsy were more likely to be preterm, have brain injury, and be discharged home on antiseizure medication, although the results were not significant after adjusted analysis.
    Conclusions: The risk of epilepsy was lower and age at onset was older than in previous reports, which may be related to multiple factors including a neurocritical care approach, treatment of hypoxic-ischemic encephalopathy with hypothermia, high rate of neonatal transition to palliative care, and the exclusion of neonatal onset epilepsies. Continuation of antiseizure medications in infancy did not decrease the risk of epilepsy. Long-term, multicenter studies are needed to understand whether neonatal seizure management can alter the risk of epilepsy.
    MeSH term(s) Age of Onset ; Electroencephalography ; Epilepsy/epidemiology ; Female ; Follow-Up Studies ; Humans ; Hypoxia-Ischemia, Brain/epidemiology ; Hypoxia-Ischemia, Brain/therapy ; Incidence ; Infant ; Infant, Newborn ; Infant, Newborn, Diseases ; Intensive Care, Neonatal/statistics & numerical data ; Male ; Outcome Assessment, Health Care/statistics & numerical data ; Risk Factors ; Seizures/epidemiology ; Seizures/therapy
    Language English
    Publishing date 2018-04-20
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 639164-3
    ISSN 1873-5150 ; 0887-8994
    ISSN (online) 1873-5150
    ISSN 0887-8994
    DOI 10.1016/j.pediatrneurol.2018.03.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants.

    Sivanandan, Sindhu / Bali, Varun / Soraisham, Amuchou Singh / Harabor, Andrei / Kamaluddeen, Majeeda

    American journal of perinatology

    2013  Volume 30, Issue 9, Page(s) 745–750

    Abstract: Objective: To compare the incidence of medical closure of patent ductus arteriosus (PDA) and adverse events (acute renal dysfunction, necrotizing enterocolitis, spontaneous intestinal perforation, and gastrointestinal bleeding) between preterm infants ... ...

    Abstract Objective: To compare the incidence of medical closure of patent ductus arteriosus (PDA) and adverse events (acute renal dysfunction, necrotizing enterocolitis, spontaneous intestinal perforation, and gastrointestinal bleeding) between preterm infants who received indomethacin and ibuprofen for the treatment of PDA.
    Study design: A retrospective comparative effectiveness evaluation study was conducted on preterm infants (≤32 weeks) who received indomethacin or ibuprofen for treatment of symptomatic PDA.
    Results: Of the 124 eligible infants, 54 received indomethacin and 70 received ibuprofen. The overall incidence of medical PDA closure with indomethacin was 37/54 (68.5%) as compared with 42/70 (60%) in the ibuprofen group (p = 0.32). The proportion of infants with surgical PDA ligation was similar between the two groups (18.5% in both the groups). There was no difference in the incidences of acute renal dysfunction, necrotizing enterocolitis stage ≥ 2, spontaneous intestinal perforation, and gastrointestinal bleeding between indomethacin and ibuprofen groups.
    Conclusion: Ibuprofen is as effective as indomethacin in the treatment of symptomatic PDA in preterm infants. This study also shows that both agents have similar adverse effects and the choice of one agent over the other should be based on local availability and dosing preference.
    MeSH term(s) Anti-Inflammatory Agents, Non-Steroidal ; Ductus Arteriosus, Patent/drug therapy ; Ductus Arteriosus, Patent/surgery ; Enterocolitis, Necrotizing/chemically induced ; Female ; Gastrointestinal Hemorrhage/chemically induced ; Humans ; Ibuprofen/adverse effects ; Ibuprofen/therapeutic use ; Indomethacin/adverse effects ; Indomethacin/therapeutic use ; Infant, Newborn ; Infant, Premature ; Infant, Premature, Diseases/drug therapy ; Intestinal Perforation/chemically induced ; Male ; Renal Insufficiency/chemically induced ; Retrospective Studies
    Chemical Substances Anti-Inflammatory Agents, Non-Steroidal ; Ibuprofen (WK2XYI10QM) ; Indomethacin (XXE1CET956)
    Language English
    Publishing date 2013-10
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 605671-4
    ISSN 1098-8785 ; 0735-1631
    ISSN (online) 1098-8785
    ISSN 0735-1631
    DOI 10.1055/s-0032-1332800
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Effectiveness and Safety of Indomethacin versus Ibuprofen for the Treatment of Patent Ductus Arteriosus in Preterm Infants

    Sivanandan, Sindhu / Bali, Varun / Soraisham, Amuchou Singh / Harabor, Andrei / Kamaluddeen, Majeeda

    American Journal of Perinatology

    2013  Volume 30, Issue 09, Page(s) 745–750

    Abstract: Objective: To compare the incidence of medical closure of patent ductus arteriosus (PDA) and adverse events (acute renal dysfunction, necrotizing enterocolitis, spontaneous intestinal perforation, and gastrointestinal bleeding) between preterm infants ... ...

    Abstract Objective: To compare the incidence of medical closure of patent ductus arteriosus (PDA) and adverse events (acute renal dysfunction, necrotizing enterocolitis, spontaneous intestinal perforation, and gastrointestinal bleeding) between preterm infants who received indomethacin and ibuprofen for the treatment of PDA.
    Study Design: A retrospective comparative effectiveness evaluation study was conducted on preterm infants (≤32 weeks) who received indomethacin or ibuprofen for treatment of symptomatic PDA.
    Results: Of the 124 eligible infants, 54 received indomethacin and 70 received ibuprofen. The overall incidence of medical PDA closure with indomethacin was 37/54 (68.5%) as compared with 42/70 (60%) in the ibuprofen group ( p  = 0.32). The proportion of infants with surgical PDA ligation was similar between the two groups (18.5% in both the groups). There was no difference in the incidences of acute renal dysfunction, necrotizing enterocolitis stage ≥ 2, spontaneous intestinal perforation, and gastrointestinal bleeding between indomethacin and ibuprofen groups.
    Conclusion: Ibuprofen is as effective as indomethacin in the treatment of symptomatic PDA in preterm infants. This study also shows that both agents have similar adverse effects and the choice of one agent over the other should be based on local availability and dosing preference.
    Keywords acute renal dysfunction ; ibuprofen ; indomethacin ; patent ductus arteriosus
    Language English
    Publishing date 2013-01-15
    Publisher Thieme Medical Publishers
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 605671-4
    ISSN 1098-8785 ; 0735-1631
    ISSN (online) 1098-8785
    ISSN 0735-1631
    DOI 10.1055/s-0032-1332800
    Database Thieme publisher's database

    More links

    Kategorien

To top